Active Ingredient History
N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Fibrosis (Phase 1)
Glomerulonephritis (Phase 1)
Healthy Volunteers (Phase 1)
Heart Failure (Phase 1)
Hypertension (Phase 1)
Insulin Resistance (Phase 1)
Liver Cirrhosis (Phase 1)
Obesity (Phase 1)
Ocular Physiological Phenomena (Phase 2)
Optic Disk (Phase 2)
Polycystic Kidney, Autosomal Dominant (Phase 1)
Regional Blood Flow (Phase 2)
Shock, Cardiogenic (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue